NEWS & EVENTS
VIVOSONIC AT SPEECH-LANGUAGE & AUDIOLOGY CANADA EVENT
Visit our booth (#9) at the upcoming SAC (Speech-Language & Audiology Canada) Audiology Event, May 12 and 13, in Toronto, ON, Canada. Learn about the benefits of upgrading to the Integrity™ V500 System and view a live demonstration.
VIVOSONIC AT AAA 2023
Visit our booth (#407) at the upcoming AAA Annual Meeting on April 19 to 22 in Seattle, Washington. See the newest features of our Integrity™ V500 and view a demonstration.
VIVOSONIC AT EHDI 2023
Join us at the EHDI 2023 Annual Meeting, March 5 – 7, in Cincinnati, OH. Visit our Vivosonic booth (#1) and see the latest version of our Integrity™ V500 System!
RELEASE OF INTEGRITY™ VERSION 8.11
We are pleased to inform you that we have just released software ver. 8.11 for Integrity™ G2 systems. This release includes many new exciting and convenient features, such as:
• Option to purchase as a 1-channel system (Ipsilateral recording) while allowing 2-channel patient setup and automatic channel switching — upgradeable to a 2-channel system (Ipsilateral and Contralateral recording) at any time without change of hardware
• Help (?) button on all screens for quick and easy access to instructional videos and user manuals
• New RETSPL option conforming to ISO standards in addition to currently available options
• Option to preview RETSPL values on System screen
Read more: https://bit.ly/integrity-latest-features
A study of Hyperbilirubinic and normal newborns showed that Hyperbilirubinemic newborns had decreased Medial Olivocochlear (MOC) reflex activity. This may be indicative of future problems in speech discrimination and effective hearing in noisy background. Additional long cohort studies are needed to evaluate the clinical importance of MOC reflex measurements in this group.
Obstructive sleep apnea syndrome (OSAS) is a respiratory syndrome that manifests during sleep. For the auditory system to be able to function normally, the inner ear and cochlear nerve require healthy oxygen support. The purpose of this study was to assess the hearing function of patients with OSAS and to reveal the relationship between polysomnographic parameters and hearing test results.
Vivosonic’s policy is to provide support for a period of 5 years from the date of withdrawal of a product from the market. It is now over 5 years since the sale of our last new G1 system and we currently have a limited inventory of parts available to service or repair these G1 systems. We are no longer providing software updates for these G1 systems and we no longer support Windows 7. As also previously communicated, support and parts are no longer available for the XP version.
Using the Vivosonic Integrity™ V500 System, the aim of this study was to investigate the VEMP* responses in conductive hearing loss using bone conduction stimulation. The response percentage of present VEMP waves by AC stimulation was 20% (4 ears). For BC stimulation, the rate increased to 75% (15 ears).
Leave a Reply
You must be logged in to post a comment.